Cargando…
Targeted agents in non-small cell lung cancer therapy: What is there on the horizon?
Lung cancer is a heterogeneous group of diseases. There has been much research in lung cancer over the past decade which has advanced our ability to treat these patients with a more personalized approach. The scope of this paper is to review the literature and give a broad understanding of the curre...
Autores principales: | Villaflor, Victoria M., Salgia, Ravi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622362/ https://www.ncbi.nlm.nih.gov/pubmed/23599689 http://dx.doi.org/10.4103/1477-3163.109253 |
Ejemplares similares
-
The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)
por: Salgia, Ravi, et al.
Publicado: (2021) -
LSD1-targeted therapy—a multi-purpose key to unlock immunotherapy in small cell lung cancer
por: Sattler, Martin, et al.
Publicado: (2023) -
Beyond Conventional: The New Horizon of Targeted Therapy for the Treatment of Advanced Non Small Cell Lung Cancer
por: Tartarone, Alfredo, et al.
Publicado: (2021) -
Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of Failure
por: Pathak, Ranjan, et al.
Publicado: (2020) -
Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors
por: Salgia, Ravi
Publicado: (2014)